Despite the importance of LKB1 in the AMPK-dependent antineoplastic effects of metformin, this drug abolishes the increase in tumor growth linked with high-fat diet and hyperinsulinemia, irrespective of LKB1 expression by the tumor. Here, STK11 is linked to neoplasm.